Dr. David Bell to Write Book Explaining ME/CFS Treatment Research at Cheney Clinic

Since 2003 Dr. Cheney’s innovative ME/CFS therapy research has kept a low profile – but now things may be coming together. And if you visit the brand new Cheney Clinic website you’ll find emerging news such as the following:

The Book
Pioneering ME/CFS physician-researcher Dr. David Bell, MD – recently retired from his clinical practice to focus more on research and writing – has been commissioned “by an independent party” to write a book explaining the research the Cheney Clinic has been engaged in since 2004.

Dr. Cheney (who is a PhD physicist as well as an MD) has presented technical explanations of his theories, findings, and plans via videotaped lectures over the past few years, but these tend to be hard for the lay reader to digest. Dr. Bell, on the other hand, has a unique ability to write about technical topics in simple language. (So evident in his free Lyndonville News e-newsletter – www.davidsbell.com.)

As stated at the Cheney website, Dr. Bell will explain findings from the clinic’s work in the field of echocardiography (3-D imaging that allows visualization of heart structure & function), and Dr. Cheney’s understanding of chronic fatigue syndrome as the body’s “low-energy adaptation to underlying defects in oxygen utilization.”

But beyond this, it's likely the book will tell the story of the individualized, multi-part ME/CFS treatment protocol Dr. Cheney has been developing and refining these past few years. (Outlined recently in “CFS and Stem Cells: A Warning.”)

Gut Dysbiosis Modulates Significant CFS Symptoms
Dr. Cheney notes recent publications by Dr. Kenny De Meirleir and other ME/CFS researchers suggesting that increased bacterial overgrowth in the GI tract is likely responsible for certain symptoms of CFS, and explains how this ties into his protocol.

The Best EFA Ratio for CFS Consumption – An Atypical and Surprising Choice
The essential fatty acids (e.g., omega- 3 and omega-6) are responsible for an extremely large range of cell functions, Dr. Cheney explains. He explores "the incredible finding" that the ratios and dietary sources of these EFAs considered typically beneficial in normal subjects may produce dramatically different effects in ME/CFS patients, with significant implications for the potential benefits of testing & intake modification. (A bit technical, but attention-grabbing.)

Over time, the Clinic site promises, it will add announcements of general interest on new ME/CFS research advances at the Clinic and elsewhere, plus new research abstracts, presentations, and commentary on the Cheney Clinic Blog.